US Patent 8853161 Glycopegylation methods and proteins/peptides produced by the methods
Patent 8853161 was granted and assigned to Novo Nordisk on October, 2014 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Caryn Bowe0
David A. Zopf0
David James Hakes0
Robert J. Bayer0
Shawn DeFrees0
Xi Chen0
Edits on 22 Jul, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08853161 Glycopegylation methods and proteins/peptides produced by the methods US Patent 8853161 Glycopegylation methods and proteins/peptides produced by the methods
Infobox
Patent Number
088531610
Patent Number
88531610
Edits on 1 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
088531610
Date of Patent
October 7, 2014
0Patent Application Number
132465120
Date Filed
September 27, 2011
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 27 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08853161 Glycopegylation methods and proteins/peptides produced by the methods
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08853161
Date of patent
October 7, 2014
Patent application number
13246512
Date Filed
September 27, 2011
Patent primary examiner
Find more entities like US Patent 8853161 Glycopegylation methods and proteins/peptides produced by the methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
